Bicocca Open Archive

Logo unimib boa
MONZA, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.551
AS - Asia 7.775
EU - Europa 4.850
SA - Sud America 865
Continente sconosciuto - Info sul continente non disponibili 852
AF - Africa 145
OC - Oceania 15
Totale 25.053
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.974
VN - Vietnam 2.288
SG - Singapore 2.236
CN - Cina 1.382
IT - Italia 1.303
HK - Hong Kong 803
DE - Germania 798
RU - Federazione Russa 743
BR - Brasile 661
SE - Svezia 503
CA - Canada 493
IE - Irlanda 320
GB - Regno Unito 309
IN - India 220
FR - Francia 214
BD - Bangladesh 145
KR - Corea 138
UA - Ucraina 113
FI - Finlandia 109
ID - Indonesia 103
TR - Turchia 92
AR - Argentina 76
DK - Danimarca 71
JP - Giappone 69
NL - Olanda 59
ES - Italia 55
IQ - Iraq 55
AT - Austria 51
LT - Lituania 51
MX - Messico 51
ZA - Sudafrica 51
SA - Arabia Saudita 38
PL - Polonia 35
CO - Colombia 34
PK - Pakistan 31
BE - Belgio 30
EC - Ecuador 26
CH - Svizzera 23
PH - Filippine 22
VE - Venezuela 22
PY - Paraguay 19
MA - Marocco 17
ET - Etiopia 16
UZ - Uzbekistan 16
IR - Iran 15
MY - Malesia 15
KZ - Kazakistan 13
AU - Australia 11
EG - Egitto 11
TN - Tunisia 11
CL - Cile 10
CZ - Repubblica Ceca 10
NP - Nepal 10
TW - Taiwan 10
AZ - Azerbaigian 9
CR - Costa Rica 9
KE - Kenya 9
HR - Croazia 8
JO - Giordania 8
RO - Romania 8
DZ - Algeria 7
IL - Israele 7
KG - Kirghizistan 7
UY - Uruguay 7
BG - Bulgaria 6
GR - Grecia 6
PA - Panama 6
RS - Serbia 6
AO - Angola 5
EU - Europa 5
JM - Giamaica 5
OM - Oman 5
PE - Perù 5
PT - Portogallo 5
AE - Emirati Arabi Uniti 4
BH - Bahrain 4
BO - Bolivia 4
HU - Ungheria 4
MN - Mongolia 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
AL - Albania 3
GT - Guatemala 3
LA - Repubblica Popolare Democratica del Laos 3
LY - Libia 3
MM - Myanmar 3
SC - Seychelles 3
TT - Trinidad e Tobago 3
BN - Brunei Darussalam 2
DO - Repubblica Dominicana 2
LB - Libano 2
MD - Moldavia 2
MU - Mauritius 2
NI - Nicaragua 2
NO - Norvegia 2
QA - Qatar 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TG - Togo 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 24.187
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.891
Singapore 1.390
Ashburn 881
Dallas 865
Hong Kong 775
San Jose 708
Ho Chi Minh City 668
Hanoi 574
Frankfurt am Main 517
Milan 489
Toronto 375
Wilmington 368
Chandler 358
Woodbridge 314
Dublin 310
Los Angeles 271
New York 271
Dearborn 246
Fairfield 213
Santa Clara 202
Houston 196
Beijing 171
Chicago 140
Princeton 140
Boardman 139
Nanjing 116
Jacksonville 110
Seoul 110
The Dalles 108
Hefei 105
Seattle 103
Council Bluffs 84
Rome 83
Lauterbourg 78
Buffalo 77
Shanghai 77
Da Nang 75
Jakarta 73
Guangzhou 72
Moscow 68
Cambridge 65
Orem 63
Haiphong 61
Helsinki 58
São Paulo 58
Munich 50
Dong Ket 49
Biên Hòa 44
Basingstoke 43
Ha Long 42
Vilnius 40
Nanchang 38
Tokyo 38
Columbus 36
Montreal 36
Vienna 36
Hải Dương 35
Lawrence 35
Ninh Bình 35
Nuremberg 35
Brooklyn 34
Bắc Giang 34
Denver 33
Hangzhou 33
Pune 33
Altamura 32
Quận Bình Thạnh 32
Can Tho 31
Shenyang 31
Chennai 30
Vũng Tàu 29
Atlanta 28
Baghdad 28
Warsaw 28
London 27
Zhengzhou 27
Rio de Janeiro 25
Carate Brianza 24
Johannesburg 24
Phoenix 24
Thái Nguyên 24
Tianjin 24
Brussels 23
Stockholm 22
Ottawa 21
Poplar 21
Shangdi 21
Manchester 20
Phủ Lý 20
Quận Một 20
Andover 19
Fremont 19
Kunming 19
San Diego 19
Turku 19
Changsha 18
Kent 18
Quận Phú Nhuận 18
San Francisco 18
Bắc Ninh 17
Totale 15.695
Salva come PNG Salva come JPEG
Nome #
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 586
CHARACTERIZATION OF AXONAL DEGENERATION MECHANISMS IN BORTEZOMIB-TREATED SENSORY NEURONS 557
Head down tilt 15° in experimental intracerebral hemorrhage: a randomized non-inferiority safety trial 553
INSIGHT ON BORTEZOMIB INDUCED MICROTUBULES STABILITY AND MITOCHONDRIAL TRAFFICKING 495
Head Down Tilt 15° in Acute Ischemic Stroke with Poor Collaterals: A Randomized Preclinical Trial 486
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 469
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 436
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 416
Selective Cerebrospinal Fluid Hypothermia: Bioengineering Development and In Vivo Study of an Intraventricular Cooling Device (V-COOL) 407
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 405
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 399
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 388
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 387
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 375
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 368
Multi-site laser Doppler flowmetry for assessing collateral flow in experimental ischemic stroke: Validation of outcome prediction with acute MRI 366
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 359
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 356
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 348
In vitro models for studying oxaliplatin neurotoxic effects 345
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 336
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 333
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 329
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 327
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 327
Cerebral collateral therapeutics in acute ischemic stroke: A randomized preclinical trial of four modulation strategies 324
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 322
An in vitro model of dorsal root ganglion (DRG) neurons to investigate the molecular mechanisms of oxaliplatin-induced peripheral neuropathy. 321
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 316
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 314
Incubation with low doses of oxaliplatin modifies the electrophysiological properties of dorsal root ganglion neurons 311
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 308
An in vivo and in vitro neurophysiological approach to acute and chronic oxaliplatin-induced peripheral neurotoxicity 305
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 303
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 302
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 300
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 297
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 296
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 288
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 284
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 282
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 282
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 280
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 280
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 276
Multimodal experimental approach to the study of human neurological diseases 270
Thermal plantar test in experimental ischemic stroke 269
MITOCHONDRIAL DYSFUNCTION IS A FEATURE OF PACLITAXEL AND OXALIPLATIN-PROMOTED CHEMOTHERAPY-INDUCED PERIPHERAL NEUROTOXICITY 266
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 265
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 257
Cerebral collateral therapeutics in experimental ischemic stroke: a randomized preclinical trial of four modulation strategies 255
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 252
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 241
Head down tilt 15° to preserve salvageable brain tissue in acute ischemic stroke: A pre-clinical pooled analysis, with focus on cerebral hemodynamics 240
INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 238
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 236
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 235
ACCURATE NEUROPHYSIOLOGICAL MONITORING FOR SENSORY NEUROPATHY IN MOUSE MODELS OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROTOXICITY 234
Pathogenesis of platinum-induced peripheral neurotoxicity: Insights from preclinical studies 234
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 230
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 227
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 222
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 218
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 217
How to assess models of oxaliplatin induced peripheral neurotoxicity – a neurophysiological translational approach 213
Advanced neurophysiology - a translational approach to neuropathy and neuropathic pain 213
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 213
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 211
Translating morphology from bench side to bed side via neurophysiology: 8-minute protocol for peripheral neuropathy research 211
Erratum: Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy (Proceedings of the National Academy of Sciences of the United States of America (2021) 118 (e2012685118) DOI: 10.1073/pnas.2012685118) 208
Pharmacokinetics of IVIg in Wistar rats 206
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 206
EMG Recordings at Rest to Verify Axonal Hyperexcitability in a Rat Model of Oxaliplatin Induced Peripheral Neurotoxicity 204
Human Immunoglobulins ameliorate pain in rats with bortezomib-induced peripheral neuropathy 203
Early stimulation of trek channel transcription and activity induced by oxaliplatin-dependent cytosolic acidification 202
A mechanistic understanding of the relationship between skin innervation and chemotherapy-induced neuropathic pain 194
STANDARD AND ADVANCED NEUROPHYSIOLOGY SET UP IN MOUSE MODELS: SENSORY RECORDINGS AND NERVE EXCITABILITY TESTING OF THE CAUDAL NERVE. 191
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 190
Neurofilament light protein: a blood biomarker of neurodegeneration in chemotherapy-induced peripheral neurotoxicity. 178
Topiramate neuroprotectant effects against oxaliplatin induced peripheral neurotoxicity 178
MORPHOFUNCTIONAL CHARACTERIZATION OF CIPN 170
Oxaliplatin induced Peripheral Neurotoxicity (OIPN): a Rat Model that full encompasses all OIPN Phenomena 168
Nerve Excitability Testing: An In Vivo Translational Approach To Investigate Oxaliplatin Induced Peripheral Neurotoxicity Pathogenesis And Treatment 166
Oxaliplatin induced peripheral neurotoxicity: nerve excitability testing full profile in a long term toxicity animal study 160
UNVEILING THE MICROVASCULAR NETWORK ALTERATIONS IN THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM OF RATS EXPOSED TO NEUROTOXIC CHEMOTHERAPY 157
The Link between Bench and Bed-Side: “clinical” neurophysiological approach to a rat model of neuropathy 135
TOPIRAMATE PREVENTS OXALIPLATIN ACUTE PERIPHERAL NEUROTOXICITY. 126
Totale 25.053
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.637
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.637
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.207 122 164 133 116 84 96 60 54 49 63 84 182
2022/20231.828 198 362 223 187 155 304 58 84 120 31 64 42
2023/20241.293 56 46 59 76 144 292 191 75 63 32 40 219
2024/20253.884 163 470 343 160 320 141 300 138 422 582 318 527
2025/202611.294 2.150 1.027 1.215 871 992 538 1.477 397 676 785 591 575
2026/2027239 239 0 0 0 0 0 0 0 0 0 0 0
Totale 25.053